A Short Review on Allogeneic Stem Cell Transplant in Leukemic Patients
- *Corresponding Author:
- Doyer Mellen
320 W 10th Avenue
Columbus, OH 43210, USA
E-mail: [email protected]
Received July 25, 2013; Accepted July 31, 2013; Published August 02, 2013
Citation: Mellen D, Nyle H (2013) A Short Review on Allogeneic Stem Cell Transplant in Leukemic Patients. J Bone Marrow Res 1:130. doi:10.4172/2329-8820.1000130
Copyright: © 2013 Mellen D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
To identify potential barriers to reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (ASCT) in patients with chronic lymphocytic leukemia (CLL) we performed a retrospective review of patients referred for transplant consultation at our center. Of the 209 patients evaluated, a substantial proportion of patients who were appropriate candidates for RIC-ASCT were unable to attain disease control to proceed (18.3%) with this therapy.